HAIRY CELL LEUKEMIA
Clinical trials for HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to wipe out rare blood cancer
Disease control OngoingThis study is testing whether a combination of two drugs, vemurafenib (a pill) and obinutuzumab (an infusion), can effectively treat people newly diagnosed with hairy cell leukemia, a rare blood cancer. The goal is to see if this treatment can lead to a complete remission, meanin…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pill tested to control Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a daily pill called ibrutinib for people with hairy cell leukemia that has returned after previous treatment. The goal is to see if the drug can control the cancer by blocking a protein that helps the cancer cells grow. Researchers will measure how well pati…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC